Related references
Note: Only part of the references are listed.Azathioprine metabolite measurements are not useful for following treatment of autoimmune hepatitis in Alaska Native and other non-Caucasian people
Elizabeth D. Ferucci et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing
M. V. Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis
Dermot Gleeson et al.
GUT (2011)
Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis
Albert J. Czaja et al.
GASTROENTEROLOGY (2010)
Diagnosis and Management of Autoimmune Hepatitis
Michael P. Manns et al.
HEPATOLOGY (2010)
Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis
Ulf Hindorf et al.
JOURNAL OF HEPATOLOGY (2010)
Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response
Marten Werner et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Severe hepatotoxicity with high 6-methylmercaptopurine nucleotide concentrations after thiopurine dose escalation due to low 6-thioguanine nucleotides
Sharon J. Gardiner et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2008)
Medication-taking behavior in a cohort of patients with inflammatory bowel disease
Isabel Bernal et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Prospective analysis of Nonadherence in autoimmune hepatitis: A common problem
Nanda Kerkar et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2006)
The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia
Lynne Lennard et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis
Michael A. Heneghan et al.
JOURNAL OF HEPATOLOGY (2006)
Thiopurine methyltransferase deficiency and azathioprine intolerance in autoimmune hepatitis
Albert J. Czaja et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: A meta-analysis
MT Osterman et al.
GASTROENTEROLOGY (2006)
Nodular regenerative hyperplasia and thiopurines: The case for level-dependent toxicity
NKH de Boer et al.
LIVER TRANSPLANTATION (2005)
Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome
JJ Feld et al.
HEPATOLOGY (2005)
Selective inhibition of inflammatory gene expression in activated T lymphocytes: A mechanism of immune suppression by thiopurines
CW Thomas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease
S Wright et al.
GUT (2004)
6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease
MC Dubinsky et al.
GASTROENTEROLOGY (2002)
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
MC Dubinsky et al.
GASTROENTEROLOGY (2000)